A rare stumble at TJX has Wall Street spooked. We see a buying opportunity

TJX shares are down ~6% since its after-hours results, after Marmaxx comparable sales rose just 1% in fiscal Q2 2027 versus 3% expected, a key driver of the sell-off. Despite this miss, overall revenue grew 5.4% y/y to $15.18B and EPS rose 10.9% to $1.22, slightly above the $15.17B consensus and $1.19 EPS estimate. Citi and Gordon Haskett downgraded TJX (Citi: buy/neutral and PT cut from $182 to $154; Haskett: hold with $155 PT) citing Marmaxx underperformance versus peers, though UBS defended the stock and expects a fast remediation with management already seeing August improvements.

Analysis

Near term, the market is likely pricing this as more than an execution slip because TJX’s multiple has been built on consistency, not just growth. The key mechanism is not lost demand but a confidence shock: when the largest banner underperforms, investors start discounting store traffic quality, buying discipline, and the durability of margin leverage. That can keep the stock under pressure for 1-4 weeks even if August improves, because sell-side revisions usually lag by a cycle.

The clearest relative winner is ROST, which now has a cleaner execution narrative and can widen the valuation gap if its next print confirms better merchandising. TGT could benefit only indirectly if the message becomes that consumers are trading across value channels rather than abandoning them, but the more likely effect is that off-price peers with sharper assortment will take incremental share from TJX first. Over 6-18 months, the structural bull case for TJX still works if management fixes mix and international/new concepts add growth, but the market will want proof that Marmaxx re-accelerates before re-rating the stock.

The contrarian point is that consensus may be over-penalizing one quarter because this business has high operating leverage to buying accuracy, so a modest assortment correction can restore comps faster than the market expects. What would falsify the buy-the-dip case is another subpar Marmaxx comp next quarter or any indication that share loss is moving from execution issue to brand erosion. If that happens, TJX deserves a lower multiple; if not, the current drawdown is likely a better entry than a warning signal for the whole off-price group.

Key Decisions for Investors

• TJX: buy weakness only if management commentary and August read-through remain constructive; preferred entry is after the first post-earnings flush stabilizes. Risk/reward is attractive for 6-12 months if Marmaxx re-accelerates, but cut exposure if the next comp print stays below low-single-digit growth.
• ROST vs TJX pair: long ROST / short TJX for the next earnings window. Thesis is relative execution dispersion, with TJX paying a penalty for one miss while ROST can monetize the comparison if it posts another clean print.
• If already long TJX, hedge with a short-dated put spread into the next monthly sales update rather than selling core stock. That protects against another data point showing the issue is not a one-quarter anomaly.
• Watch TGT only as an indirect beneficiary/pressure gauge, not a primary trade. If TGT’s value proposition looks stronger in upcoming traffic data, it would validate broader share migration away from TJX and weaken the dip-buy thesis.